Biodesix to Report Fourth Quarter and Full Year 2023 Financi

Biodesix, Inc. , a leading diagnostic solutions company with a focus in lung disease, announced today that it will release financial results for the fourth quarter and year ended December 31, 2023...

Related Keywords

, Biodesix Inc , Nasdaq , Nodify Lung , Diagnostic Cortex , Artificial Intelligence , Private Securities Litigation Reform Act , Risk Factors , Markets ,